According to OSE Immunotherapeutics's latest financial reports the company's current earnings are NZ$72.71 Million. In 2024 the company made an earning of NZ$71.38 Million, an increase over its 2023 earnings that were of -NZ$44.21 Million. The earnings displayed on this page is the company's Pretax Income.